Dallas, United States
Dialectic Therapeutics Inc, founded in 2018, is a clinical-stage biotechnology company based in Texas, with a mission aptly summarized by its slogan: "Creating Innovative and New Technologies to End Cancer." The company is dedicated to developing pioneering technologies aimed at treating cancer, focusing on targeted therapies that minimize toxicities and complications.
Headquartered in Dallas, Texas, Dialectic maintains collaboration with prestigious institutions like UT Health San Antonio and University of Florida Health. The founding team combines expertise from industry leaders, including biotech venture investors John D. Harkey, Jr. and Dr. David Genecov, along with academic pillars like Dr. Robert Hromas, Dr. Daohong Zhou, and Dr. Guangrong Zheng.
Their financial backing included a $500.00K early VC investment as of 01 October 2020. This underscores investors' confidence in their innovative approach and market potential in the cancer therapy sector.
University Health